| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 28/01/2020 | 18:24 | GlobeNewswire Inc. | Applied Therapeutics, Inc. Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchas... | NASDAQ:APLT | Applied Therapeutics Inc |
| 24/01/2020 | 03:28 | GlobeNewswire Inc. | Applied Therapeutics, Inc. Announces Upsizing and Pricing of Public Offering of 2,741,489 Shares of Common Stock | NASDAQ:APLT | Applied Therapeutics Inc |
| 21/01/2020 | 22:16 | GlobeNewswire Inc. | Applied Therapeutics, Inc. Announces Offering of 1,750,000 Shares of Common Stock | NASDAQ:APLT | Applied Therapeutics Inc |
| 08/01/2020 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Announces Positive Topline Results of Pivotal Phase 2 ACTION-Galactosemia Study of AT-007 in Galactosemi... | NASDAQ:APLT | Applied Therapeutics Inc |
| 23/12/2019 | 17:57 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) | NASDAQ:APLT | Applied Therapeutics Inc |
| 23/12/2019 | 12:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:APLT | Applied Therapeutics Inc |
| 19/12/2019 | 23:38 | Edgar (US Regulatory) | Securities Registration Statement (s-1/a) | NASDAQ:APLT | Applied Therapeutics Inc |
| 19/12/2019 | 00:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:APLT | Applied Therapeutics Inc |
| 16/12/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics to Ring Nasdaq Closing Bell on December 17th | NASDAQ:APLT | Applied Therapeutics Inc |
| 13/12/2019 | 22:58 | Edgar (US Regulatory) | Securities Registration Statement (s-1) | NASDAQ:APLT | Applied Therapeutics Inc |
| 06/12/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Announces Presentation of Pre-Clinical Data Highlighting AT-001 for Treatment of Diabetic Cardiomyopathy... | NASDAQ:APLT | Applied Therapeutics Inc |
| 05/12/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Announces Presentations Outlining the Design and Rationale for the ARISE-HF Pivotal Study of AT-001 for ... | NASDAQ:APLT | Applied Therapeutics Inc |
| 21/11/2019 | 19:18 | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without Registration (d) | NASDAQ:APLT | Applied Therapeutics Inc |
| 15/11/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Announces Presentation of Clinical Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy... | NASDAQ:APLT | Applied Therapeutics Inc |
| 13/11/2019 | 22:04 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:APLT | Applied Therapeutics Inc |
| 13/11/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Reports Third Quarter 2019 Financial Results | NASDAQ:APLT | Applied Therapeutics Inc |
| 12/11/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics, Inc. Announces Pricing of $20 Million Private Placement of Common Stock | NASDAQ:APLT | Applied Therapeutics Inc |
| 16/10/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics to Present Data Highlighting AT-007 for the Treatment of Galactosemia at the American Society of Human G... | NASDAQ:APLT | Applied Therapeutics Inc |
| 17/09/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics to Present Preclinical Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy at the 55th... | NASDAQ:APLT | Applied Therapeutics Inc |
| 13/09/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics to Present Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy at the Heart Failure So... | NASDAQ:APLT | Applied Therapeutics Inc |
| 04/09/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Announces Initiation of Phase 3 Registrational Trial of AT-001 in Diabetic Cardiomyopathy (ARISE-HF) | NASDAQ:APLT | Applied Therapeutics Inc |
| 28/08/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics to Present at Baird’s 2019 Global Healthcare Conference | NASDAQ:APLT | Applied Therapeutics Inc |
| 12/08/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Reports Second Quarter 2019 Financial Results | NASDAQ:APLT | Applied Therapeutics Inc |
| 08/08/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Reports AT-007 SAD Data from Healthy Volunteer Portion of Phase 1/2 ACTION-Galactosemia Study | NASDAQ:APLT | Applied Therapeutics Inc |
| 24/06/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Announces Initiation of Phase 1/2 Study of AT-007 in Galactosemia | NASDAQ:APLT | Applied Therapeutics Inc |
| 21/06/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics Reports First Quarter 2019 Financial Results | NASDAQ:APLT | Applied Therapeutics Inc |
| 07/06/2019 | 13:30 | GlobeNewswire Inc. | Applied Therapeutics to Present Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy in Late Breaking Sessio... | NASDAQ:APLT | Applied Therapeutics Inc |
| 28/05/2019 | 13:30 | GlobeNewswire Inc. | Applied Therapeutics Announces FDA Orphan Drug Designation for AT-007 in Galactosemia | NASDAQ:APLT | Applied Therapeutics Inc |
| 24/05/2019 | 13:00 | GlobeNewswire Inc. | Applied Therapeutics to Present Data at ESC-HF Highlighting AT-001, a Novel, Potent and Selective Aldose Reductase Inhibitor ... | NASDAQ:APLT | Applied Therapeutics Inc |